Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Li

P3.01-64 Preliminary Data of Diverse Therapies in Patients With Advanced Non–Small-Cell Lung Cancer Harbouring RET-Rearrangement

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-114 the Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients With Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.04-07 Pemetrexed Enhances Anti-Tumor Efficacy of PD-L1 Blockade by Promoting Intra-Tumor Immune Response via Tumor and T Cell-Intrinsic Mechanisms

Journal of Thoracic Oncology

Respiratory Medicine

English

P116 Real World Data of 1st Line A+T in Advanced EGFR+ NSCLC: Clinical Outcome, PFS Influential Factors and Acquired Resistance

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.13-21 Apatinib Plus Icotinib as First-Line Therapy for EGFR Co-Mutations NSCLC in Chinese Patients: An Exploratory Study

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-59 a Better Real World Practice for ROS1 Positive NSCLC Patients, Driven by the Targeted Next Generation Sequencing(NGS) and the Targeted TKI

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-56 Concurrent Mutations in Chinese Lung Cancer Patients Carrying HER2 Genomic Aberrations

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-65 Assessment of Individual and Combined of Five Serum Tumor Markers for Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.04-03 NF-κB and HIF-1α Play Important Roles in Regulating PD-L1 Expression by EGFR or KRAS Mutants in Non-Small Cell Lung Cancer Cells

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.12-01 a Single-Arm Multi-Center Phase II Study of Apatinib in Patients With ES-SCLC After Second/Third-Line Chemotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English